Reports
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
Ferrous fumarate liquid | |||
Ferrous fumarate tablets | |||
Ferrous gluconate tablets | If patient intolerant of sulphate. |
||
Ferrous sulphate tablets | High relative cost. |
||
Fexofenadine | High relative cost |
||
Finasteride 5mg tablets | Men |
||
Flucinolone acetonide 0.025% ointment | |||
Flucitasone and salmeterol | |||
Flucitasone and salmeterol (Seretide®) | For existing patients, for paediatric use only (i.e. up to 18 years of age) - APC listing of current formulary brands |
||
Flucitasone furoate (Avamys) | Approved for use in children and adults. Previous APC decision reviewed in December 2015. |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.